trending Market Intelligence /marketintelligence/en/news-insights/trending/poedyxymp7maykilqvgmda2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

AbbVie enters $3B credit agreement

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


AbbVie enters $3B credit agreement

AbbVie Inc. entered a credit agreement for a $3 billion unsecured revolving credit facility.

Borrowings under the agreement may, at AbbVie's election, bear interest at the base rate plus an applicable margin of 0.000% to 0.325% per annum, or the Eurocurrency rate plus an applicable margin of 0.700% to 1.325% per annum.

Additionally, the North Chicago, Ill.-based drugmaker repaid all outstanding obligations and terminated all outstanding commitments under a revolving credit agreement dated Aug. 18, 2014. The agreement was also for a $3 billion unsecured revolving credit facility.

JPMorgan Chase Bank, N.A. acted as administrative agent for both credit agreements.